Stocks Slightly Higher as Bond Yields Decline

Equities are slightly higher as investors await the FOMC meeting results, with expectations for unchanged rates and focus on the Fed's dot plot and economic projections; geopolitical tensions and potential US involvement in the Israel-Iran conflict are limiting gains. Weaker-than-expected US housing data put downward pressure on bond yields, while Nucor and Marvell Technology are leading individual stock gainers after positive company-specific news, contrasting with declines in pharmaceutical stocks due to potential advertising restrictions and Bitdeer Technologies after announcing a convertible note offering.

Analysis

US stock indexes, including the S&P 500 (+0.07%), Dow Jones Industrials (+0.06%), and Nasdaq 100 (+0.10%), are exhibiting slight gains as investors remain largely on the sidelines ahead of the Federal Open Market Committee (FOMC) meeting results. Market participants anticipate no change in interest rates, focusing instead on the Fed's dot plot and updated projections for growth, unemployment, and interest rates, alongside Fed Chair Powell's subsequent commentary for future policy cues. Modest stock gains were maintained after US weekly initial unemployment claims fell by 5,000 to 245,000, meeting expectations. However, weaker-than-expected US housing data for May, with housing starts plunging -9.8% m/m to a 5-year low of 1.256 million and building permits unexpectedly falling -2.0% m/m to a 4-3/4 year low of 1.393 million, contributed to a decline in the 10-year T-note yield by -2 bp to 4.36%. US MBA mortgage applications also fell -2.6% in the week ended June 13, despite the average 30-year fixed mortgage rate decreasing by 9 bp to 6.84%.

Market sentiment is tempered by significant geopolitical risks, particularly the escalating hostilities between Israel and Iran, now in their sixth day, and speculation of potential US involvement following a meeting between President Trump and his national security team. These tensions, along with reports of "extreme jamming" disrupting shipping signals in the Strait of Hormuz and causing a tanker collision, are limiting equity upside and supporting safe-haven demand for T-notes. Furthermore, investors are bracing for potential negative tariff news, as President Trump indicated intentions to issue letters regarding unilateral tariffs to US trading partners within one to two weeks. Overseas markets are mixed, with the Euro Stoxx 50 down -0.46% while Japan's Nikkei 225 rose +0.90%. ECB Governing Council member Panetta highlighted substantial risks to Eurozone prospects from US tariffs and Middle East conflicts.

Individual stock movements are notable: Nucor (NUE) surged over +5% on a strong Q2 EPS forecast ($2.55-$2.65 vs. $2.30 consensus). Marvell Technology (MRVL) gained over +6% after increasing its data center total addressable market estimate to $94 billion by 2028. JPMorgan Chase (JPM) rose over +1% on reports of potential easing of bank capital rules. Conversely, pharmaceutical stocks like Merk & Co (MRK) and Eli Lilly (LLY) declined over -1% due to concerns about potential restrictions on direct-to-patient advertising. Bitdeer Technologies (BTDR) dropped over -8% after announcing a $300 million convertible senior notes offering. Zoetis (ZTS) fell over -3% following a downgrade by Stifel, and Allstate (ALL) was down over -1% after reporting a 31% m/m increase in May catastrophe losses to $777 million.

Key Decisions for Investors

• Maintain a cautious stance pending the FOMC meeting's outcome, paying close attention to the Fed's economic projections, dot plot, and Chair Powell's remarks for insights into future monetary policy.
• Closely monitor escalating geopolitical tensions in the Middle East, particularly any signs of US involvement or further disruption to the Strait of Hormuz, as these could significantly increase market volatility and impact energy prices.
• Assess potential impacts from impending US tariff announcements on specific sectors and companies with significant international trade exposure.
• Evaluate company-specific news, differentiating between positive catalysts like Nucor's strong guidance and Marvell Technology's expanded market outlook, versus negative pressures such as potential regulatory changes for pharmaceutical firms or increased loss provisions for insurers like Allstate.
• Scrutinize the sharp decline in May housing starts and building permits, which hit multi-year lows despite a slight easing in mortgage rates, as a potential leading indicator of broader economic softening.